跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺适得 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ranibizumab Injections
Approved
生物制品
Ranibizumab Injections
Novartis Pharma Schweiz AG
🇨🇳 National Medical Products Administration
Approval Date
Nov 17, 2022
Approval ID
286f886113ceb31b
Company
Novartis Pharma Schweiz AG
Type
生物制品
Approval Details
Approval Id
286f886113ceb31b
Approval Number
国药准字SJ20181010
Generic Name
雷珠单抗注射液
Generic Name En
Ranibizumab Injections
Trade Name
诺适得
Drug Type
生物制品
Dosage Form
注射剂
Strength
10mg/ml,每支装量0.165ml
Reg Date
2022-11-17
Expired Date
2027-11-16
Company Name
Novartis Pharma Schweiz AG
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path
/organization/novartis-pharma-schweiz-ag
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 17, 2022
Approval ID
286f886113ceb31b
Type
生物制品
Back to NMPA Approvals